Lancet Oncol.

2017/10/01

Tanimoto T, Oshima K, Tsuda K, Mori J, Shimmura H. Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma. Lancet Oncol. 18:e557, 2017.(Oct)

https://www.ncbi.nlm.nih.gov/pubmed/28971816

Share on Facebook
Share on Twitter
Please reload